Tags: Drug.
Dacetuzumab (also known as SGN-40 or huS2C6) is a humanized monoclonal antibody being developed for the treatment of CD40-positive cancers like non-Hodgkin’s lymphoma and hematological malignancies.This drug was developed by Seattle Genetics Inc.
Loading...
This page contains content from the copyrighted Wikipedia article "Dacetuzumab"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.